Contact the team

The PREDNOS 2 trial team are always here to help. For further information about the PREDNOS 2 trial please contact us:

General enquiries

For general queries about the study, site set-up and queries about collection of data and data anaylsis please contact the Birmingham Clinical Trials Unit.

Email: prednos2@trials.bham.ac.uk

Postal address:

PREDNOS 2 Trial Office
Birmingham Clinical Trials Unit (BCTU)
School of Health and Population Sciences
College of Medical and Dental Sciences
Public Health Building
University of Birmingham
Edgbaston
Birmingham B15 2TT

Freepost address:

PREDNOS 2 Trial Office
FREEPOST RRKR-JUZR-HZHG
Birmingham Clinical Trials Unit (BCTU)
School of Health and Population Sciences
College of Medical and Dental Sciences
Public Health Building
University of Birmingham
Edgbaston
Birmingham B15 2TT

PREDNOS 2 trial staff:

Elizabeth Brettell Trials Manager  0121 415 9130

Emma Barsoum Trial Co-ordinator 0121 415 9132

Noreen Akhtar Trials Administrator  0121 415 9131

Charmaine Meek Trial Administrator 0121 415 9132

Terry Hughes Data Manager 0121 415 9131

Adam Khan Data Manager 0121 415 9131

 

Find out more information about our other renal trials

BCTU
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit in the School of Medicine specialising in the design, conduct and analysis of clinical trials.

eGFR-C
Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease: prospective longitudinal study in a multi-ethnic population.

GloMY
GloMY is a national, multi-centre, randomised controlled open-label pilot trial of Myfortic plus short course steroids versus standard care in patients with proteinuric primary focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN).

PEXIVAS
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.

PREDNOS
Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial

STOP-ACEi
STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.